Grünenthal Meds
Andrew M. serves as the Vice President of Supply Chain and a Member of the Board of Directors at Grünenthal Meds since August 2023. With extensive experience in supply chain management, Andrew has held various leadership roles, including Vice President of Supply Chain at Kyowa Kirin International plc. and Managing Director at KSM Management Consulting Limited. Additionally, Andrew has contributed to organizations such as the Scottish Salmon Company and the Centre for Process Innovation Limited. As a longstanding Director of The Katie McKerracher Trust since June 2009, Andrew remains engaged in philanthropy. Andrew's academic credentials include an MBA from the University of Strathclyde and a B.Sc. Hons in Chemistry from The University of Edinburgh, along with an Advanced Diploma in Procurement and Supply from the Chartered Institute of Procurement & Supply.
This person is not in any teams
This person is not in any offices
Grünenthal Meds
1 followers
Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.